ESP, Orphan renal deal

ESP Pharma ( Edison, N.J.) licensed from Orphan Therapeutics (Lebanon, N.J.) exclusive U.S. and Canadian marketing and distribution rights to intravenous terlipressin, a synthetic analog of vasopressi...